(1R)-phenylamino-(2S)-2-aryl-2-azaaryl cyclopentane as well as preparation method and application thereof
A technology based on cyclopentane and aniline, applied in the field of synthesis of chiral quaternary carbocyclopentane, can solve the problems of limited application, and achieve the effects of no metal involved, mild reaction conditions, and environmental friendliness
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] (1 R )-anilino-(2 S )-2-(4'-methylphenyl)-2-(2'-pyridyl)cyclopentane III-1 The specific preparation steps are as follows:
[0036]
[0037]Preparation process: Take a dry 25 mL schlenk tube, add 53.2 mg (0.4 mmol) N-phenylcyclopropane, 39.0 mg (0.2 mmol) 2-(1-(4´-methylphenyl) vinyl) pyridine, DPZ (0.35 mg, 0.001 mmol), BA (33.3 mg, 0.04 mmol), and then add 5 mL of cyclopentyl methyl ether (CPME), cover the bottle, and remove it with a vacuum pump at no higher than -78 °C. Gas 2-3 times, 5-10 min each time, pass through argon gas for protection, then place it at 25°C, and irradiate with a 3 W blue light with a wavelength of 410-510 nm at a distance of about 3 cm from the schlenk tube, and react 8 hours, after the reaction was completed, separated by column chromatography (petroleum ether / ethyl acetate = 20 ~ 4:1, volume ratio), concentrated by rotary evaporation, and dried in vacuum (dried at 25°C for 1 hour) to obtain 60.4 mg of yellow oil (1 R )-anilino-(2 S )...
Embodiment 2
[0039] (1 R )-anilino-(2 S )-2-(4'-fluorophenyl)-2-(2'-pyridyl)cyclopentane III-2 The specific preparation steps are as follows:
[0040]
[0041] In this example, the 2-(1-(4´-methylphenyl)vinyl)pyridine in Example 1 is replaced with 2-(1-phenylvinyl)-3-picoline, other steps Same as Example 1, obtain 59.8 mg yellow oil (1 R )-anilino-(2 S )-2-(4´-fluorophenyl)-2-(2´-pyridyl)cyclopentane III-2 in 90% yield and 82% enantiomeric excess. NMR and mass spectrometry data are: 1 HNMR (300 MHz, CDCl 3 ) δ 8.57 (d, J = 4.1 Hz, 1H), 7.56 (t, J = 7.5 Hz, 1H),7.26 (t, J = 6.8 Hz, 3H), 7.12 (m, 3H), 6.98 (t, J = 8.7 Hz, 2H), 6.66 (m,3H), 4.95 (t, J = 5.1 Hz, 1H), 3.30 (br, 1H), 2.62 (t, J = 7.3 Hz, 2H), 2.17(m, 1H), 1.92 (dt, J = 15.6, 9.7 Hz, 1H), 1.69 (m, 2H); 13 C NMR (75 MHz, CDCl 3 ) Δ 165.4, 163.1, 159.8, 148.7, 147.5, 139.1, 139.0, 136.4, 130.4,130.3, 129.1, 121.6, 117.0, 115.2, 113.3, 60.9, 36.0,30.6, 20.5; m / z 333.1762 (M+H + ), calc. for C 22 h 22 FN ...
Embodiment 3
[0043] (1 R )-anilino-(2 S )-2-phenyl-2-(2'-(3'-methyl)pyridyl)cyclopentane III-3 The specific preparation steps are as follows:
[0044]
[0045] In this example, the 2-(1-(4´-methylphenyl)vinyl)pyridine in Example 1 is replaced with 2-(1-phenylvinyl)-3-picoline, other steps Same as Example 1, obtain 57.1 mg yellow oil (1 R )-anilino-(2 S )-2-phenyl-2-(2´-(3´-methyl)pyridyl)cyclopentane III-3 in 87% yield and 71% enantiomeric excess. NMR and mass spectrometry data are: 1 HNMR (300 MHz, CD 2 Cl 2 ) δ 8.37 (d, J = 4.0 Hz, 1H), 7.42 – 7.18 (m, 4H), 7.07(dd, J = 14.9, 7.4 Hz, 5H), 6.58 (dd, J = 13.8, 7.4 Hz, 3H), 5.26 – 5.12 (m,1H), 3.23 (br, 1H), 3.04 – 2.73 (m, 1H), 2.25 (dt, J = 12.8, 6.6 Hz, 1H),2.18 – 2.03 (m, 1H), 1.96 (d, J = 6.6 Hz, 1H), 1.76 (s, 3H), 1.71 – 1.59 (m,1H), 1.49 (td, J = 18.9, 9.4 Hz, 1H); 13 C NMR (75 MHz, CDCl 3 ) δ 163.7, 144.8,143.1, 139.7, 132.0, 128.8, 128.2, 128.1, 126.5, 121.4, 114.0, 60.6, 34.5,30.6, 26.9, 21.0, 20.1; HRMS (ES...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


